Shire
SHP
Real-time BATS EUROPE - 07/19 05:30:00 pm
4449.5GBp
+0.88%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Develops and markets medicines for patients with rare diseases

Shire Plc is a biopharmaceutical company.

It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs.

The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol.

Shire was founded in 1986 and is headquartered in Dublin, Ireland.
Managers
Name Title
Flemming Ornskov Chief Executive Officer & Executive Director
Susan Saltzbart Kilsby Non-Executive Chairman
Thomas J. W. Dittrich Chief Financial Officer & Director
Howard Mayer Chief Medical Officer
Matthew Walker Head-Technical Operations
Andreas Eugen Busch Chief Scientific Officer
Steven H. Gillis Independent Non-Executive Director
Sara Mathew Independent Non-Executive Director
Albert P. L. Stroucken Independent Non-Executive Director
Gail D. Fosler Independent Non-Executive Director
Shareholders
Name Equities %
Glenview Capital Management LLC 6,001,684 1.97%
T. Rowe Price Associates, Inc. 3,164,989 1.04%
Paulson & Co., Inc. 2,952,200 0.97%
Henderson Global Investors Ltd. 1,898,106 0.62%
Davis Selected Advisers LP 1,860,234 0.61%
Manulife Asset Management (US) LLC 1,846,057 0.61%
Maverick Capital Ltd. 1,713,431 0.56%
Harding Loevner LP 1,632,219 0.54%
Fidelity Management & Research Co. 1,599,266 0.52%
Davis Selected Advisers - NY, Inc. 1,590,778 0.52%
Company contact information
22 Grenville Street
JE4 8PX St. Helier, Jersey, Channel Islands
United Kingdom

Phone : +44 (0)12 56 894 160
Fax : +44
Internet : http://www.shire.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, Nasdaq 100, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  JE00B2QKY057
- Bloomberg Code :  SHP
- Reuters Code :  SHP.L
- Datastream Code :  SHP
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
SHIRE12.92%52 831
JOHNSON & JOHNSON-7.59%346 292
PFIZER3.95%220 236
ROCHE HOLDING LTD.-4.77%200 995
NOVARTIS-2.11%200 139
MERCK AND COMPANY11.85%168 225
AMGEN10.87%128 318
ABBOTT LABORATORIES10.04%110 100
SANOFI0.92%104 422
GLAXOSMITHKLINE18.25%101 396
BAYER-9.17%101 370
ELI LILLY AND COMPANY6.05%97 222
NOVO NORDISK A/S-3.87%95 160
ASTRAZENECA9.47%93 044
BRISTOL-MYERS SQUIBB COMPANY-7.59%92 564
CELGENE CORPORATION-17.80%62 226
ALLERGAN PLC7.38%59 560
JIANGSU HENGRUI MEDICINE CO LTD39.65%39 919
TAKEDA PHARMACEUTICAL CO LTD-27.31%33 424
ASTELLAS PHARMA INC25.21%31 855
DAIICHI SANKYO COMPANY, LIMITED57.14%28 710